Search our website

Headline indicators from the Opinions and Lifestyle Survey covering the period 1 December 2021 to 3 January 2022 by disability and clinically extremely vulnerable status.

1-year and 5-year net-survival estimates for men, women and persons in England, by NHS Region, Cancer Alliance, and Sustainability and Transformation Partnerships.

1-year cancer survival by Clinical Commissioning Group for all cancers combined, three cancers combined, breast, colorectal and lung. 1-, 5- and 10-year index of cancer survival estimates are also available by Sustainability and Transformation Partnerships and Cancer Alliances.

1-year and 5-year age-standardised net survival (per cent) for men, women and all adults diagnosed with cancer of the colon: England, NHS Region, Clinical Senate, Area Team

1-year and 5-year age-standardised net survival (per cent) for women diagnosed with cancer of the breast and cervix, and men diagnosed with cancer of the prostate: England, NHS Region, Clinical Senate, Area Team

1-year and 5-year age-standardised net survival (per cent) for men, women and all adults diagnosed with cancer of the oesophagus: England, NHS Region, Clinical Senate, Area Team

1-year and 5-year age-standardised net survival (per cent) for men, women and all adults diagnosed with cancer of the lung: England, NHS Region, Clinical Senate, Area Team

1-year and 5-year age-standardised net survival (per cent) for men, women and all adults diagnosed with cancer of the stomach: England, NHS Region, Clinical Senate, Area Team

1-year and 5-year age-standardised net survival (per cent) for men, women and all adults diagnosed with cancer of the bladder: England, NHS Region, Clinical Senate, Area Team

1-year cancer survival by Clinical Commissioning Group for all cancers combined, three cancers combined, breast, colorectal and lung. 1-, 5- and 10-year index of cancer survival estimates are also available by Sustainability and Transformation Partnerships and Cancer Alliances.